Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Boehringer Ingelheim
AstraZeneca
Express Scripts
Cipla
Covington
Federal Trade Commission
Teva

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084393

« Back to Dashboard

NDA 084393 describes NITROFURAZONE, which is a drug marketed by Ambix, Lannett, Perrigo New York, Taro, and Wendt, and is included in seven NDAs. Additional details are available on the NITROFURAZONE profile page.

The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
Summary for 084393
Tradename:NITROFURAZONE
Applicant:Lannett
Ingredient:nitrofurazone
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084393

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;TOPICALStrength0.2%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Julphar
Accenture
US Army
Dow
Farmers Insurance
Argus Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.